Oncolytics Biotech
ONCY
#9206
Rank
HK$0.84 B
Marketcap
HK$7.87
Share price
3.80%
Change (1 day)
28.04%
Change (1 year)

Earnings for Oncolytics Biotech (ONCY)

Earnings in 2025 (TTM): -HK$0.2 Billion

According to Oncolytics Biotech 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$0.2 Billion a decrease over its 2023 earnings that were of -HK$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oncolytics Biotech from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.2 Billion-2.32%
2024 -HK$0.2 Billion1.01%
2023 -HK$0.2 Billion23.39%
2022 -HK$0.16 Billion-1.98%
2021 -HK$0.17 Billion9.1%
2020 -HK$0.15 Billion22.64%
2019 -HK$0.13 Billion22.78%
2018 -HK$98.83 Million4.1%
2017 -HK$94.93 Million4.87%
2016 -HK$90.52 Million8.75%
2015 -HK$83.23 Million-37.06%
2014 -HK$0.14 Billion-26.2%
2013 -HK$0.18 Billion-37.39%
2012 -HK$0.29 Billion28.8%
2011 -HK$0.23 Billion46.02%
2010 -HK$0.16 Billion35.64%
2009 -HK$0.12 Billion-14.2%
2008 -HK$0.14 Billion-0.52%
2007 -HK$0.14 Billion24.6%
2006 -HK$0.11 Billion45.34%
2005 -HK$72.59 Million-11.8%
2004 -HK$82.3 Million115.36%
2003 -HK$38.22 Million13.86%
2002 -HK$33.56 Million-5.45%
2001 -HK$35.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Aeterna Zentaris
AEZS
-HK$42.77 Million-77.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$175.43 B-90,559.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$62.62 B-32,390.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$13.81 B-7,223.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
-HK$0.23 Billion 16.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
-HK$5.97 Billion 2,974.61%๐Ÿ‡บ๐Ÿ‡ธ USA